Skip to main navigation

Vertex Websites

Choose your region

Americas
- Canada
- United States
Asia Pacific
- Australia
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
Middle East
- GCC
Rest of the world
- Global / EN

Don't see your region/country
listed? Visit our global website

Choose your region

Newsroom
Press Releases
News Alert

Newsroom
Press Releases
News Alert

Media Library

Corporate Images
Corporate Logos
Headshots
Reports and Resources
Videos

Media inquiries:

mediainfo@vrtx.com

+1 617 341 6992

+44 20 3204 5275

Newsroom

Newsroom

Leadership team

Latest Press Releases

View all

Jul 01, 2026

Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia

Jun 11, 2026

Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions

Jun 05, 2026

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference

View all

Featured Media Library Items

View all

Reshma Kewalramani, M.D.

Reshma Kewalramani, M.D.

Chief Executive Officer and President

Download

Duncan McKechnie

Duncan McKechnie

Executive Vice President and Chief Commercial Officer

Download

Vertex International Headquarters – Lobby

Vertex International Headquarters – Lobby

Download

View all

Newsroom Home
Press Releases
Media Library

Privacy
Terms of Use
Your Privacy Choices

Facebook
Twitter
LinkedIn
Instagram
Youtube

© 2026 Vertex Pharmaceuticals Incorporated